Vaccine antigen (processed by immune system)

Vaccine antigens processed by the immune system refers to a pharmacological classification where the therapeutic agent does not interact with a single, discrete molecular target such as a receptor or enzyme. Instead, the agent introduces an immunogen—such as a viral protein, an inactivated pathogen, or genetic material (mRNA/DNA) encoding an antigen—into the body (CDC, 2023). These components are recognized by the innate immune system and captured by professional antigen-presenting cells (APCs) like dendritic cells (StatPearls, 2023). The antigens are proteolytically processed into peptides and displayed on Major Histocompatibility Complex (MHC) molecules to activate T-lymphocytes and B-lymphocytes (NIH, 2022). This orchestration leads to the production of specific antibodies and the generation of memory cells, providing long-term protection against specific pathogens or malignant cells (WHO, 2021). Because the effect is mediated through a systemic biological process rather than a single molecular interaction, it is categorized in pharmacological databases as having no discrete molecular target (DrugBank, 2024).

Other names

ImmunogenVaccine componentAntigenic determinantEpitopeVaccine antigen

Induction of active immunity through the introduction of antigens that are processed by antigen-presenting cells and presented via MHC molecules to activate T-cells and B-cells.